|Last Price$5.82||Day Change (%)-0.51%|
|Open Price$5.84||Day Change ($)-0.03|
|Day Range5.82–5.93||52-Week Range4.29–5.96|
As of Thu 12/05/2013 04:22 PM EST | USD
Lack of competitive advantages may mean these companies aren't the bargains they seem to be.
We see opportunity as fleeing investors trigger an irrational sell-off.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
The five biotech ETFs have very different portfolios with markedly different performance.